Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Scinai Immunotherapeutics Ltd ADR
(NQ:
SCNI
)
3.500
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.500
Bid (Size)
3.000 (10)
Ask (Size)
3.600 (4)
Prev. Close
3.500
Today's Range
3.500 - 3.500
52wk Range
2.230 - 8.920
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
New Toolkit Launched to Boost Marburg Screening Readiness in the US
October 31, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Pipeline and CDMO Services at BIO-Europe 2024
October 31, 2024
Via
Investor Brand Network
Performance
YTD
-42.59%
-42.59%
1 Month
-6.91%
-6.91%
3 Month
-4.37%
-4.37%
6 Month
-18.81%
-18.81%
1 Year
-49.28%
-49.28%
More News
Read More
Researchers Shine Spotlight on New Barriers to Vaccination
October 14, 2024
Via
Investor Brand Network
Exposures
COVID-19
Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost
September 25, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel Solution
September 16, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Episode of BioMedWire Podcast
September 09, 2024
Via
Investor Brand Network
New Approach Could Boost Effectiveness of Immunotherapies Against Colorectal Cancer
September 04, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement
August 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
August 20, 2024
Via
Investor Brand Network
SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q2 2024
August 15, 2024
Via
InvestorPlace
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update
August 15, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuring Agreement with EIB Converting Debt into Equity
August 13, 2024
Via
Investor Brand Network
Australia Launches Novel Immunotherapy Program to Help Babies with Peanut Allergies
August 09, 2024
Via
Investor Brand Network
7 F-Rated Stocks for Your August 2024 Sell List
August 05, 2024
Via
InvestorPlace
Study Highlights Heightened Risk of Diseases Spreading from Animals to Humans
July 26, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives PEI Feedback Regarding Development, Preclinical Trial of Anti-IL-17 NanoAb
July 23, 2024
Via
Investor Brand Network
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
July 15, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 15, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
PLUG Stock Alert: Plug Power Gets Approval for HyVia Acquisition
July 15, 2024
Via
InvestorPlace
M Stock Plunges 13% as Macy’s Calls Off Take-Private Talks
July 15, 2024
Via
InvestorPlace
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
July 15, 2024
Via
Benzinga
Why Is Scinai Immunotherapeutics (SCNI) Stock Up 56% Today?
July 15, 2024
Via
InvestorPlace
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study
July 15, 2024
Via
Investor Brand Network
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
July 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.